Clinically obesity, sluggishness, poor hair coat and a non-significant increase in body weight were observed in group II rats in comparison with the control group I rats (
Faheemuddin et al., 2013). Results of TEC, PCV and Hb% of group I rats was normal and non-significant throughout the experimental period. Total leukocyte count in the hyperlipidemic diet-fed group II was non-significantly higher when compared to the control group.
Mohamed Anwar et al., (2008), who observed increased WBC and lymphocyte levels in rabbits that were fed with high cholesterol diet (Table 1) (
Huang et al., 2001).
Rats on hyperlipidemic diet showed a significant (P<0.05) increase in serum TC, TG, LDL-C, VLDL-C and a significant decrease in HDL-C compared with control rats received standard basal diet throughout the experimental period (
Naiel Abbass et al., 2012;
Rahaman et al., 2013). Increased serum lipid parameters in the present study might be due to hyperlipidemic diet and it indicated that the diet under trial had established hyperlipidemia in this group of rats.
Hyperlipidemic diet significantly (P<0.05) increased the atherogenic index by the end of experiment in the hyperlipidemic diet-fed group II rats compared to control rats fed on the standard diet (
Rahman et al., 2013;
Harini et al., 2016). It indicates that HDL-C (Good cholesterol) is decreased in proportion to increased TC, LDL-C and it is significantly (P<0.05) evidenced by all serum biochemical parameters (Table 1).
Hyperlipidemic diet-fed group II rats revealed grossly pale and enlarged liver in most of the rats (Fig 1). Microscopically, microvesicular hepatic steatosis was observed predominantly and macrovesicular fatty change in a few rats (Fig 2) (
Olubukula et al., 2012). Liver steatosis was absent in the control group.
Aorta from hyperlipidemic diet-fed group II rats revealed moderate initiation of atherosclerotic lesions with degeneration of endothelial cells, subintimal lipid-laden macrophages (foam cells), slight thickening of the tunica intima with the proliferation of few SMCs. Disruption of the elastic lamina of tunica media with structural and directional changes in the myocytes was also seen in a few cases. Atheromatous plaque consisted of foam cells and SMCs and in some thrombus formation in the aorta was also evident. Similar changes were also observed in the aorta of rabbits fed with 1% cholesterol for seven weeks (
Olubukula et al., 2012). Disruption of the elastic lamina of tunica media with structural and directional changes in the myocytes was also seen in a few cases.
Coleman et al., (2006) Stary et al., (1995) also described thrombus formation in the aorta of humans as a type VI atherosclerotic lesion. No atherosclerotic changes were observed in the control group I rats.
CD 31 expression was noticed in ECs, platelets and most of the leukocyte subsets and at the endothelial cellular junctions (Fig 3) It might be due to the high level of platelets and other leukocytes in the atherosclerotic lesions and at the junction of thrombus in the hyperlipidemic diet-fed group II. CD31 is proatherogenic and expressed throughout the atheroma of the aorta (
Newman 2003;
Woodfin et al., 2007). PECAM-1 has both pro and anti-inflammatory roles in atherosclerosis (
Harry et al., 2008;
Goel et al., 2008).
CD 44 IHC antibody positivity was observed in the endothelial cell degeneration, subendothelial foam cell accumulation and in the thrombus also in the small blood vessels of cardiac muscle fibers with a few fat cells with attached microthrombus (Fig 4). The complete absence of CD 44 reaction was observed in the control group I. CD 44 mediates endothelial adhesion of lymphocyte and monocyte and stimulates cytokine release from macrophages and participates in the dedifferentiation of smooth muscle cells. CD44 also acts in atherosclerotic plaque destabilization and neointimal proliferation (
Protasiewicz and Adamiec 2005;
Sojberg 2007).
E cadherin positivity was observed in the endothelial damaged regions, foam cell accumulated areas, thrombus attached parts and the initiated atherosclerotic plaques of the large aorta and in the small cardiac vessels of the group II rats (Fig 5). Other than lesion parts of the vessel showed no reaction with E cadherin IHC antibody indicating its selective staining of lesions. Control group I revealed typical histological structures of the aorta without E cadherin positivity. Selective expression of E cadherin was observed in the atherosclerotic lesions of the group II rats indicates that it is playing a role in the initiation and progression of the atherosclerotic lesions.
Yuri et al., (1998) reported that the pattern of E cadherin expression is different in different types of atherosclerotic lesions.
Subendothelial degeneration, subintimal fat vacuolation, small atheromatous plaque consisting of various necrotic cells and thrombus are majorly stained with Beta-catenin immunohistochemical antibody (Fig 6). No positive staining of β-catenin in the control group I aorta.
Aurelie et al., (2008) reported modest Beta-catenin positive staining in the disrupted human atherosclerotic plaques. The cadherin-catenin complex is a target for many cell signaling pathways involved in adhesion, proliferation and cell motility (
Hoschuetzky et al., 1994).